Substituted 1,5-naphthyridine azolidinones as cdk inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/435 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2602757

The present invention provides novel, substituted 1,5-naphthyridine azolinones of formula (I) which inhibit Cdkl and are selective against Cdk2 and Cdk4. These compounds and their pharmaceutically acceptable salts have antiproliferative activity and are useful as anti-cancer agents.

La présente invention concerne de nouvelles 1,5-naphtyridineazolidinones substituées de formule (I) qui inhibent CdkI et sont sélectives vis-à-vis de Cdk2 et Cdk4. Ces composés et leurs sels de qualité pharmaceutique présentent une activité antiproliférative et peuvent être employés en tant qu'agents anticancéreux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted 1,5-naphthyridine azolidinones as cdk inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 1,5-naphthyridine azolidinones as cdk inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1,5-naphthyridine azolidinones as cdk inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1803742

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.